Pharmaceutical Industry requests expansion of tax deduction for R&D

With the Government's reorganization of the tax system by reducing the tax for the middle class, individuals and corporations that aim to boost the Pharmaceutical Industry are strongly requesting for the expansion of the tax return and deduction system to activate the research and development of new medicines.

Kim Jeong-Su, chairman of KPMA, Yu Sung-Phil, chairman of the board of directors...